Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair - Concepedia

Concepedia

Publication | Open Access

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

DOI Full Paper Access

39

Citations

39

References

2017

Year

Ana-Alicia López-Iglesias, Ana B. Herrero, Marta Chesi, Laura San‐Segundo, Lorena González-Méndez, Susana Hernández-García, Irena Misiewicz-Krzemińska, Dalia Quwaider, Montserrat Martín-Sánchez, Daniel Primo,

Journal of Hematology & Oncology

References

	Year	Citations

Page 1